We separately analyzed theoretical changes in program spending for one biosimilar product (ZIEXTENZO, Q5120) that has reported negative ASP data for all NDCs for three consecutive quarters beginning with the second calendar quarter of 2022, and calculated the payment limit under our proposed method for biosimilars with negative or zero ASP data and changes in program spending for the three impacted quarters had our proposed payment approach been applied
Switching down is straightforward: just go down one level at a time over weeks
Keeping up with changing state laws in this area can be challenging
This price difference is not because of the tobacco brand
They removed his jaw, said Dot, they took a bone from his leg and used it in his jaw, cut across his lip and around to his throat. Robert had a tracheotomy, feeding tube, chemo, high intensity radiation and a second surgery, but the aggressive cancer continued to grow